Diabetes Prevention (cont.)Medical Author:
Melissa Conrad Stöppler, MD
Melissa Conrad Stöppler, MDMelissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology. Medical Editor:
William C. Shiel Jr., MD, FACP, FACR
William C. Shiel Jr., MD, FACP, FACRDr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology. In this Article
Are there medications that can help to prevent type 2 diabetes?The answer is yes. As described previously, metformin has been shown in the DPP trial to prevent the development of diabetes in those with impaired glucose tolerance. While not quite as effective as intensive lifestyle change, metformin decreased the rate of progression from 29% in the placebo group to 22%. The American Diabetes Association has recommended metformin for the prevention of diabetes in very high-risk individuals. Another class of drugs called the thiazolidinediones (pioglitazone [Actos] and rosiglitazone [Avandia]) has been shown to be beneficial in prevention of type 2 diabetes. Drugs in this class have also been studied extensively in patients who have had gestational diabetes, and there is a significant reduction in the annual rates of progression to diabetes (5.4% compared to 12.1% with placebo). Avandia, however, has been associated with an increased risk of heart attack and stroke, on September 23, 2010, the U.S. Food and Drug Administration (FDA) announced that it will significantly restrict the use of the diabetes drug rosiglitazone (Avandia) to patients with type 2 diabetes who cannot control their diabetes on other medications such as pioglitazone (Actos). Acarbose (Precose), a drug designed to reduce small intestinal absorption of carbohydrates has been used with some success as well. The STOP NIDDM trial showed that in about 1400 patients with impaired glucose tolerance, acarbose significantly reduced progression to diabetes compared to placebo. REFERENCES: Reviewed by William C. Shiel Jr., MD, FACP, FACR on 6/5/2012 Patient CommentsViewers share their comments
Diabetes Prevention - Symptoms
Question: What were your symptoms associated with diabetes?
Diabetes Prevention - Gestational Diabetes Risk
Question: Did you have gestational diabetes and later develop type 2 diabetes? Please discuss your experience.
Diabetes Prevention - Diet
Question: If you are at risk for diabetes, what changes have you made in your diet? Please share your experience.
Diabetes Prevention - Risk Factors
Question: Are you concerned that you may have the risk factors for diabetes?
|
Get the latest health and medical information delivered direct to your inbox FREE!


